STRS Ohio’s Dianthus Therapeutics DNTH Stock Holding History

STRS Ohio’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$224K	Buy	+2,300	New	+$201K	﹤0.01%	1543
2022 Q2	–	Sell	-75	Closed	-$3K	–	2102
2022 Q1	$3K	Hold	75	–	–	﹤0.01%	2121
2021 Q4	$5K	Hold	75	–	–	﹤0.01%	2164
2021 Q3	$8K	Hold	75	–	–	﹤0.01%	2208
2021 Q2	$11K	Hold	75	–	–	﹤0.01%	2197
2021 Q1	$14K	Hold	75	–	–	﹤0.01%	2117
2020 Q4	$9K	Hold	75	–	–	﹤0.01%	2110
2020 Q3	$8K	Hold	75	–	–	﹤0.01%	2139
2020 Q2	$9K	Hold	75	–	–	﹤0.01%	2104
2020 Q1	$7K	Hold	75	–	–	﹤0.01%	1957
2019 Q4	$18K	Hold	75	–	–	﹤0.01%	1982
2019 Q3	$12K	Hold	75	–	–	﹤0.01%	2010
2019 Q2	$17K	Hold	75	–	–	﹤0.01%	2040
2019 Q1	$19K	Hold	75	–	–	﹤0.01%	1970
2018 Q4	$6K	Hold	75	–	–	﹤0.01%	2046
2018 Q3	$14K	Buy	+75	New	+$15.8K	﹤0.01%	2062

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

STRS Ohio's DNTH Position: Q2 2026 in Review

STRS Ohio opened a new position in Dianthus Therapeutics (DNTH) in Q2 2026: 2,300 shares worth $224K. The stake represents ﹤0.01% of the portfolio and ranks #1543 among its holdings. This is a return to the name: STRS Ohio previously reported a position in DNTH as recently as Q1 2022.

STRS Ohio first reported a position in DNTH in Q3 2018 and has held it in 16 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

STRS Ohio held 2,300 shares of Dianthus Therapeutics worth $224K as of Q2 2026.
Dianthus Therapeutics was a new STRS Ohio position in Q2 2026.
Dianthus Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1543 holding.
STRS Ohio first reported a position in Dianthus Therapeutics in Q3 2018 and has held it in 16 quarters since.
270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.